Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at SAR 73.9B, ahead of Merck & Co (SAR 54.6B) and Novartis (SAR 42.9B). Figures as of 18 Nov 2026, 21:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSAR 73.9B
- Median
- SAR 2.2B
- Combined market value
- SAR 18.98T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SAR 73.9B | SAR 2.46T | SAR 1,022.90 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | SAR 54.6B | SAR 1.27T | SAR 516.81 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | SAR 42.9B | SAR 1.1T | SAR 582.19 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | SAR 38.3B | SAR 456.7B | SAR 223.41 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SAR 32B | SAR 678.8B | SAR 391.90 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | SAR 31.9B | SAR 424.4B | SAR 176.75 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | SAR 27.3B | SAR 4.62T | SAR 5,186.70 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | SAR 21.4B | SAR 1.04T | SAR 670.53 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | SAR 19.6B | SAR 1.9T | SAR 1,072.82 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | SAR 19.1B | SAR 510.2B | SAR 2,012.22 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | SAR 17.1B | SAR 172.9B | SAR 1,513.90 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | SAR 16.9B | SAR 365.3B | SAR 182.22 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | SAR 14.7B | SAR 651.9B | SAR 147.90 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | SAR 14B | SAR 254.9B | SAR 79.78 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 13.3B | SAR 184.8B | SAR 158.40 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | SAR 11.7B | SAR 366.9B | SAR 3,546.68 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | SAR 8.7B | SAR 130.4B | SAR 320.97 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | SAR 6.4B | SAR 117.9B | SAR 191.19 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | SAR 6.2B | SAR 75.1B | SAR 560.40 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | SAR 5.8B | SAR 92.2B | SAR 2,165.60 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | SAR 5.3B | SAR 105.3B | SAR 145.28 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 5.2B | SAR 59.7B | SAR 929.39 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | SAR 5B | SAR 87.2B | SAR 76.07 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SAR 4.9B | SAR 44.6B | SAR 230.42 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | SAR 4.3B | SAR 599.9B | SAR 105.25 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | SAR 3.7B | SAR 18.9B | SAR 225.92 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | SAR 3.4B | SAR 21.6B | SAR 31.77 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | SAR 3.4B | SAR 11.8B | SAR 60.95 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | SAR 2.6B | SAR 66.5B | SAR 1,014.01 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | SAR 2.3B | SAR 148.1B | SAR 257.58 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | SAR 2.2B | SAR 27.5B | SAR 314.45 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | SAR 2.1B | SAR 57B | SAR 292.62 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | SAR 2B | SAR 50.1B | SAR 100.15 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | SAR 1.9B | SAR 98.6B | SAR 449.37 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | SAR 1.5B | SAR 29.5B | SAR 175.73 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | SAR 1.4B | SAR 17.1B | SAR 102.74 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | SAR 1.3B | SAR 32B | SAR 1,144.77 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | SAR 1.3B | SAR 23.8B | SAR 586.02 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SAR 1.2B | SAR 26.4B | SAR 502.63 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | SAR 1.2B | SAR 18.2B | SAR 104.32 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | SAR 1.1B | SAR 22.6B | SAR 346.93 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | SAR 1.1B | SAR 28.6B | SAR 82.07 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | SAR 967.1M | SAR 15B | SAR 109.23 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 849.8M | SAR 22.9B | SAR 161.71 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | SAR 845M | SAR 31.5B | SAR 39.39 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 745.3M | SAR 34.7B | SAR 1,493.20 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | SAR 656.2M | SAR 22.4B | SAR 1,120.46 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 621.2M | SAR 28B | SAR 356.53 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 613.4M | SAR 46.8B | SAR 56.19 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | SAR 481.6M | SAR 31.1B | SAR 476.98 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | SAR 459.6M | SAR 26.8B | SAR 192.50 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | SAR 452M | SAR 27.8B | SAR 254.28 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SAR 349M | SAR 18.1B | SAR 188.45 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SAR 321.5M | SAR 36.1B | SAR 380.58 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | SAR 296.9M | SAR 37.5B | SAR 248.02 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | SAR 276.8M | SAR 18.1B | SAR 51.61 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | SAR 229.4M | SAR 17B | SAR 155.18 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 203.7M | SAR 31B | SAR 446.52 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | SAR 191.6M | SAR 17.7B | SAR 315.01 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | SAR 176.1M | SAR 24.4B | SAR 359.12 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | SAR 81.6M | SAR 19.8B | SAR 468.35 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (SAR 73.9B), Merck & Co (SAR 54.6B) and Novartis (SAR 42.9B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 21:48 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of SAR 18.98T as of 18 Nov 2026, 21:48 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.